Furthermore, treatment of neutrophils of CGD individuals with LaCl3 (TrxR-1 inhibitor) prevented the nuclear accumulation of TRX-1, and, as a consequence, decreased the LPS-stimulated production of TNF-α (Fig. 5B,D). The gene discussed is TXNRD1; the disease is chronic granulomatous disease.